Binge-eating Disorder Treatment Market to Grow with a CAGR of 7.25% through 2028
Increasing prevalence of binge-eating disorder and rising awareness
are factors driving the Global Binge-eating Disorder Treatment Market in the forecast
period 2024-2028.
According to TechSci Research report, “Binge-eating
Disorder Treatment Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Binge-eating
Disorder Treatment Market stood at USD 571.32 million in 2022 and is
anticipated to grow with a CAGR of 7.25% in the forecast period, 2024-2028. The global healthcare landscape has witnessed a significant
transformation over the past few decades, with growing awareness and
understanding of mental health conditions. One such condition that has garnered
increased attention is Binge-eating Disorder (BED). There is a
growing recognition of the significance of mental health in society, which has
led to increased awareness of conditions like BED. As a result, more individuals
are seeking help and clinicians are better equipped to diagnose the disorder.
The greater awareness is driving demand for effective treatments, thereby
fostering market growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Binge-eating Disorder Treatment Market.”
In recent years, there have been
advancements in the development of evidence-based treatments for BED.
Cognitive-behavioural therapy (CBT), interpersonal therapy, and medication
options have shown promising results in helping individuals manage their symptoms
and reduce binge eating episodes. The availability of these effective treatment
options has boosted the demand for BED treatment, driving market growth.
Healthcare policy changes, especially in
developed countries, have made it easier for individuals to access mental
health services, including treatment for BED. The expansion of insurance
coverage and the inclusion of mental health services in healthcare packages
have made treatment more accessible and affordable for many, further driving
market growth. Reducing the stigma associated with
mental health conditions, including eating disorders, has encouraged more
individuals to seek help. As public discourse around mental health becomes more
open and accepting, individuals with BED are more likely to reach out for
treatment, contributing to the expansion of the market.
The Global Binge-eating Disorder Treatment Market is
segmented into type, distribution channel and company.
Based on distribution channel, the offline segment has
emerged as the predominant market leader. Offline distribution channels facilitate the
development of personalized treatment plans tailored to the specific needs of
each patient. This customization is essential for effective BED treatment,
given that the disorder's presentation and underlying causes can vary greatly
from one individual to another. In some cases, medication may be prescribed as part of
the BED treatment. Offline channels enable physicians to closely monitor the
patient's response to medication, make necessary adjustments, and provide
support for any side effects or concerns.
Based on region, North America segment is expected to
grow during the forecast period. North America boasts world-class
healthcare facilities and expertise, providing the ideal environment for the
testing, deployment, and clinical validation of artificial womb technology.
Hospitals and research centers in the United States and Canada have the
necessary infrastructure and healthcare professionals to support the use of
these innovative devices for premature babies and high-risk pregnancies.
The Asia Pacific region is experiencing rapid market
growth. Asia Pacific’s strong market presence and strategic geographical
location facilitate the global commercialization of artificial womb facilities.
This position allows companies in the region to reach both domestic and
international markets more effectively, providing a competitive edge that is
essential for global market dominance.
Major companies operating in Global Binge-eating
Disorder Treatment Market are:
- Viatris Inc.
- Johnson and Johnson
- Lupin Ltd.
- Omeros Corp.
- Pyramid Healthcare Inc.
- Sumitomo Pharma Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Eli Lilly and Co
- Tonix Pharmaceuticals Holding Corp.
- Tryp Therapeutics Inc.
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“The Global Binge-eating Disorder Treatment Market is
poised for substantial growth in the coming years, driven by increasing
awareness of the disorder, advances in treatment options, changes in healthcare
policies, and the overall reduction in the stigmatization of mental health
issues. As more individuals seek help for BED, and as research continues to
enhance our understanding of the condition, the market for effective treatments
is likely to expand, offering hope to those affected by this serious mental
health disorder.,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Binge-eating Disorder Treatment Market By Type (Antidepressants,
Anticonvulsants, Stimulants, Others), By Distribution Channel (Offline, Online), By
Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Binge-eating Disorder Treatment Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Binge-eating Disorder Treatment Market.
Contact Us-
TechSci Research LLC
420 Lexington Avenue, Suite
300,
New York, United States-
10170
M: +13322586602
Email: [email protected]
Website: www.techsciresearch.com